TOPLINE Public vaccine company Novavax announced today that it will receive up to $388 million from the Coalition for Epidemic Preparedness (CEPI) to continue development and manufacturing of its COVID-19 vaccine candidate.
{iframe}https://www.forbes.com/sites/leahrosenbaum/2020/05/11/vaccine-company-novavax-gets-388-million-grant-for-coronavirus-vaccine/#276cffb07c23{/iframe}